Arcoma AB (ARCOMA) — Cash Flow-to-Debt Ratio
Arcoma AB (ARCOMA) has a Cash Flow-to-Debt Ratio of -0.01x as of September 2025, meaning its operating cash flow of Skr-308.00K could theoretically repay 0% of its total liabilities (Skr24.58 Million) in one year. See ARCOMA free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Arcoma AB Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Arcoma AB across 13 annual periods. Also explore net asset momentum of Arcoma AB to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Arcoma AB (2012–2024)
Year-by-year debt coverage analysis for Arcoma AB. For market capitalisation and broader financial context, see how much is Arcoma AB worth.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.89x | Skr18.84 Million | Skr21.13 Million | ▲ +55.0% |
| 2023 | 0.58x | Skr19.16 Million | Skr33.30 Million | ▲ +17602.3% |
| 2022 | 0.00x | Skr-179.00K | Skr54.46 Million | ▲ +94.0% |
| 2021 | -0.05x | Skr-1.93 Million | Skr35.23 Million | ▼ -136.4% |
| 2020 | 0.15x | Skr6.85 Million | Skr45.50 Million | ▼ -48.3% |
| 2019 | 0.29x | Skr11.10 Million | Skr38.14 Million | ▲ +23981.4% |
| 2018 | 0.00x | Skr45.00K | Skr37.24 Million | ▲ +100.4% |
| 2017 | -0.33x | Skr-8.91 Million | Skr27.28 Million | ▼ -137.3% |
| 2016 | -0.14x | Skr-4.67 Million | Skr33.90 Million | ▲ +4.5% |
| 2015 | -0.14x | Skr-4.95 Million | Skr34.34 Million | ▼ -552.4% |
| 2014 | -0.02x | Skr-828.00K | Skr37.48 Million | ▲ +89.1% |
| 2013 | -0.20x | Skr-11.82 Million | Skr58.35 Million | ▲ +12.5% |
| 2012 | -0.23x | Skr-10.27 Million | Skr44.35 Million | — |